Novaseek Research and hc1.com® Partner to Expand Offerings to Clinical Laboratories for Improved Performance and Increased Revenue
CAMBRIDGE, Mass. and INDIANAPOLIS, Sept. 27, 2017 (GLOBE NEWSWIRE)-
“Together Novaseek Research and hc1.com offer unprecedented value to hospitals and clinical labs that are under increased pressure to meet greater demands while facing reduced reimbursements,” said Andrei Soran, Chief Executive Officer, Novaseek Research. “The technology solutions provided via this partnership offer labs a full range of options for improving financial and operational efficiencies while empowering them to take a bigger role in advancing precision medicine using real world data.”
“The hc1.com platform enables labs to improve performance while identifying opportunities to increase profitable growth,” said Brad Bostic, founder and CEO of hc1.com. “Through our alliance with Novaseek, labs can now generate revenue by repurposing remnant clinical specimens, increasing the value of their work to the healthcare community while increasing revenue.”
Novaseek’s Clinical Data Network for Research (CDNR) platform is a cloud-based platform that transforms the way healthcare organizations and consented patients share biospecimens and clinical data with the research community. The platform constantly scans for laboratory biospecimens that match researchers’ detailed clinical criteria, automating what was once a manual process of biospecimen selection and chart reviews. The CDNR makes it possible to fulfill complex requests, accelerating research and driving additional revenue for clinical labs as they assume a greater role supporting biomedical research.
About hc1.com
The hc1®
About CDNR
Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time to support research and biobanking workflows before, during, and after a study. CDNR enables researchers to define patient cohorts through population analytics, access consented biospecimens and data, and advance translational medicine, clinical development, and observational studies. CDNR’s new and improved solution uses historical data and interactive analytics to meet the overlapping needs of organizations involved in clinical data.
About Novaseek
Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025